QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 专题：山东大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文 LANCET HAEMATOLOGY, 2019, 卷号: 6, 期号: 1, 页码: E12-E19 作者:  Shi, Yuankai;  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua 收藏  |  浏览/下载：17/0  |  提交时间：2019/12/11 Circulating tumor DNA to predict response and resistance by anti-PD-1 therapy in Chinese relapsed/refractory classic Hodgkin lymphoma. 会议论文 Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019 作者:  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua;  Qian, Wenbin 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/31 Sintilimab for relapsed/refractory classical Hodgkin's lymphoma: Extended follow-up on the multicenter, single-arm phase II ORIENT-1 study. 会议论文 Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019 作者:  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua;  Qian, Wenbin 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/31